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INTRODUCTION
The imidazo [1,2-a] pyrazine nucleus has been reported with a broad range of bioactivities, such as antimicrobial, antiviral, anticancer, antiulcer, anticonvulsant, anti-inflammatory, analgesic, and hypoglycemic activities (1) (2) (3) (4) . The heterocyclic ring system is also an analog ring of the imidazo[1,2-a]pyridine structure (5) , which exists in the structure of the anticonvulsant drugs zolpidem, alpidem, and saripidem (6) . Moreover, the imidazo[1,2-a]pyrazine derivative compounds have exhibited theophylline-like pharmacological properties, such as muscle relaxant, cardiotonic, and antibronchospasm activity, because of their similarity to the theophylline molecule, which includes an imidazo[1,2-a]pyrimidine ring in its structure (7) (8) (9) . According to the literature (10) , imidazo[1,2-a]pyrazine-3-(7H)-on derivative compounds were designed as a prodrug of ibuprofen, which is a strong non-steroidal anti-inflammatory drug, and is reported to have a high anti-inflammatory activity. Furthermore, there are many studies regarding the effect of imidazopyrazines on the central nervous system (CNS) (11) (12) (13) .
Objective:
The imidazopyrazine ring is a biologically active heterocyclic ring. Many hydrazide-hydrazone-possessing compounds have been reported to have interesting bioactivity, such as antibacterial, antifungal, anticonvulsant, anti-inflammatory, antituberculosis, and analgesic activities. In particular, aroyl hydrazides/hydrazone-containing hetero-rings, such as indole, pyridine, and imidazo [2,1-b] pyridine, and imidazo[1,2-a]pyrazine, have attracted special attention. We designed and synthesized N-(4-substitutedbenzylidene)imidazo[1,2-a]pyrazine-2-carbohydrazide (2a-j) derivatives using the two aforementioned pharmacophoric units based on the synthetic procedure indicated in our previous study.
Methods:
The structures of the compounds were elucidated using 1 H-NMR, 13 C-NMR, and mass spectroscopy. Ten final compounds were screened for their possible in vivo antinociceptive activity using a hot plate and acetic acid-induced writhing tests. In addition, the potential anticonvulsant activities of these compounds were evaluated using the PTZ-induced seizure test. A rotarod test was performed to examine probable neurological deficits because of the test compounds. Results: In the hot plate tests, none of the test compounds in the series demonstrated a significant effect. However, compound 2f, which was administrated at 100 mg/kg, significantly decreased the number of writhing behaviors in the acetic acid-induced writhing tests, indicating the antinociceptive activity of this compound. The rotarod latencies of mice were not changed by the test compounds. Furthermore, the tested compounds were ineffective in the PTZ-induced seizure tests. Conclusion: Compound 2f bearing 5-benzylidene moiety was determined as the most active compound. Keywords: Antinociceptive, hydrazone, imidazopyrazine, hot plate, writhing test Hydrazone groups, which are derived from the carboxylic acid structure, have analgesic effects and have similar effects as carboxylic acid derivatives on CNS (14) . Moreover, N-acylhydrazone has come to prominence and has acquired an important place in medicinal chemistry as an effective pharmacophoric group (15) (16) (17) .
In this study, we designed and synthesized N'-(4-substitutedbenzylidene)imidazo[1,2-a]pyrazine-2-carbohydrazide (2a-j) derivatives using the aforementioned two pharmacophoric units according to the synthetic procedure indicated. Ten final compounds were screened for their in vivo antinociceptive activity.
METHODS

General
The melting point (mp) was determined using the Electrothermal 9100 digital melting point apparatus and were uncorrected. Spectroscopic data were recorded with the following instruments: IR, Shimadzu 8400S spectrophotometer (Shimadzu, Tokyo, Japan); 
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5-Bromo-N'-(4-cyanobenzylidene)imidazo[1,2-a]pyrazine-2-carbohydrazide (2j)
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Pharmacology
Animals
Swiss albino mice, weighing 30 g to 40 g, were housed at a room temperature of 24+1°C with a 12/12-h light/dark cycle. The animals received only water 12 h before the experiments, because of the need to avoid food interference with absorption of the compounds. The experimental protocols that were used were approved by the Local Ethical Committee on Animal Experimentation of the Anadolu University, Eskişehir, Turkey. Informed consent is not required for this study.
Nociceptive tests
The compounds were screened to determine their antinociceptive activity profiles (n=6). The central component of nociception was projected from the hot plate test (18) . Furthermore, the acetic acidinduced writhing test was used to determine the potential antinociceptive activity against chemical noxious stimulus (19) . Diclofenac sodium (DCL) was used as the standard drug.
Behavioral tests
The rotarod test was performed (n=6) to examine the possible neurological deficits caused by the test compounds, which could give rise to false positives, such as muscle relaxant or impairment of the motor coordination (20) .
To evaluate the presence of anticonvulsant activity, PTZ-induced seizure tests were performed. PTZ at a dose of 80 mg/kg was applied to mice (n=10 in each group) to induce seizure (21) . The time to the appearance of the first seizure (latency, min), percentage inhibition of convulsions, and percentage inhibition of death were recorded (22) . Mice were observed over a period of 30 min; the absence of an episode of clonic spasm of at least a 5-s interval pointed out a compound's ability to abolish the effect of PTZ on seizure threshold, and these animals were thus accepted as protected (23) .
Statistical analyses
The statistical analyses of the experimental data were determined by using GraphPad Prism 3.0 software (GraphPad Software, San Diego, CA, USA). One-way analysis of variance, followed by Tukey's test were used to specify significant differences between the groups. The results were expressed as the mean±standard error of the mean (SEM). Differences between data sets were considered as significant when the p value was <0.05.
RESULTS
The present study was undertaken to synthesize ten imidazo [ were approximately 8.26-9.19 ppm. In 13 C-NMR, carbonyl carbon was assigned at about 158 ppm and the other carbons were seen at the estimated areas. In the mass spectra of compounds [M+1], the peaks were observed in agreement with their molecular formula.
According to the antinociceptive activity results, none of the test compounds in the series showed a significant antinociceptive effect in the hot plate tests (data not shown). On the other hand, compound 2f (100 mg/kg) significantly (p<0.05) inhibited writhing behavior in the acetic acid-induced writhing tests (Figure 2 ).
DISCUSSION
According to activity results, the reduction in the number of writhes after 2f treatment suggests that the mechanism of this compound may be related with a decrease in the release of inflammatory mediators in peripheral tissues or by direct blockage of its receptors, which results in an antinociceptive effect. Furthermore, this activity could be caused by an augmentation of the nociceptive threshold or by interruption of the transmission of the pain stimulus to the nerve fiber.
In the rotarod tests, none of the tested compounds altered the latency to fall from the rotating mill (data not shown), indicating that the observed antinociception in this study is unlikely to be caused by motor abnormalities.
In the PTZ-induced seizure tests, none of the tested compounds significantly altered the onset of PTZ-induced tonic convulsions or prevented the animals from PTZ-induced convulsions.
CONCLUSION
In this study, ten imidazo[1,2-a]pyrazine-2-carboxylic acid arylidenehydrazide derivatives (2a-j) have been synthesized and evaluated for their antinociceptive activity. Compound 2f bearing 5-benzylidene moiety was determined as the most active compound.
Ethics Committee Approval: Ethics committee approval was received for this study from the ethics committee of Eskişehir Anadolu University Ethics Committee on Animal Experiments. Figure 2 . The effect of diclofenac sodium (DCL, 10 mg/kg) and the test compounds (100 mg/kg) on acetic acid-induced abdominal contractions and stretches of the mice in the writhing tests. Significant differences relative to "the control group" *p<0.05, ***p<0.001. Values are given as the mean ± SEM. One-way ANOVA, post-hoc Tukey's test, n=6
